title: [Protective effects of recombinant SCR15-18 domain of human soluble complement receptor type 1 on myocardial ischemia and reperfusion injury].
abstract: OBJECTIVE
  To investigate the protective effects of recombinant SCR15-18 domain of human soluble complement receptor type 1 (sCR1-SCR-15-18) in rats underwent myocardial ischemia and reperfusion (I/R).
  
  
  METHODS
  Sprague-Dawley rats were randomly divided into three groups (n = 12 each group): sham (SO); 30 min ischemia/3h reperfusion (I/R) and I/R plus sCR1-SCR15-18 (15 mg/kg before I/R, sCR1). Serum LDH, CK and cardiac myeloperoxidase (MPO) activity were measured. Infarct size, myocardial histopathological changes and myocardial C3c were also compared among groups.
  
  
  RESULTS
  Infarct size [(16.1 +/- 3.3)% vs. (22.9 +/- 3.0)%, infarct zone/left ventricular mass, P < 0. 05] and CK [(2532.5 +/- 597.1) U/L vs. (3400.9 +/- 534.9) U/L, P < 0. 05] and LDH [(5436.2 +/- 611.3) U/L vs. (6572.0 +/- 476.3) U/L, P < 0. 05] as well as MPO activity in infarct zone [(0.81 +/- 0.14) U/g vs. (1.12 +/- 0.13) U/g, P < 0.05] were significantly decreased post sCR1 compared to I/R group. sCR1 also significantly attenuated histological myocardial injury and reduced the deposition of C3c in infarct zone.
  
  
  CONCLUSIONS
  sCR1-SCR15-18 protein exerts cardioprotective effects in this rat I/R model.
authors.affiliation: Department of Microbiology, College of Medicine, Third Military Medical University, Chongqing 400038, China.
authors.forename: Bing
authors.initials: B
authors.lastname: Tan
authors.forename: Yang-Jun
authors.initials: YJ
authors.lastname: Lan
authors.forename: De-Chun
authors.initials: DC
authors.lastname: Zhang
mesh_terms: D000818:Animals; D003402:Creatine Kinase / Q000378:metabolism; D004195:Disease Models, Animal; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D015428:Myocardial Reperfusion Injury / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D009195:Peroxidase / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D011951:Receptors, Complement / Q000627:therapeutic use*; D017463:Receptors, Complement 3b / Q000378:metabolism; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011951:Receptors, Complement; D017463:Receptors, Complement 3b; D011994:Recombinant Proteins; D007770:L-Lactate Dehydrogenase; D009195:Peroxidase; D003402:Creatine Kinase